Differential effects of dopamine receptor subtype blockade on performance of rats in a reaction-time paradigm

Psychopharmacology

Volumn 148, Issue 4, 2000, Pages 355-360

  Smith, A D ^a,c   Smith, D L ^a   Zigmond, M J ^c   Amalric, M ^b   Koob, G F ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b AIX MARSEILLE UNIVERSITY   (France)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

A69024; D1 receptor; D2 receptor; D3 receptor; Eticlopride; Motor impairment; Nafadotride; Reaction time

Indexed keywords

1 (2 BROMO 4,5 DIMETHOXYBENZYL) 1,2,3,4 TETRAHYDRO 7 HYDROXY 6 METHOXY 2 METHYLISOQUINOLINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR; ETICLOPRIDE; NAFADOTRIDE; NEUROLEPTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSOCIATION; CONDITIONED REFLEX; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG EFFECT; LOCOMOTION; MALE; MOTOR PERFORMANCE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RAT; RECEPTOR AFFINITY; RECEPTOR BLOCKING; REINFORCEMENT; RESPONSE TIME;

EID: 0034077012     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050063     Document Type: Article

References (27)

1. Amalric M, Koob GF (1987) Depletion of dopamine in the caudate nucleus but not in nucleus accumbens impairs reaction-time performance in rats. J Neurosci 7:2129-2134
2. Amalric M, Koob GF (1989) Dorsal palladium as a functional motor output of the corpus striatum. Brain Res 483:389-394
3. 2 dopamine receptor antagonism in a reaction-time task in rats. Neuropsychopharmacology 8:195-200
4. Amalric M, Moukhles H, Nieoullon A, Daszuta A (1995) Complex deficits on reaction time performance following bilateral intrastriatal 6-OHDA infusion in the rat. Eur J Neurosci 7:972-980
5. 2 receptor mRNA. Brain Res 564:203-219
6. Brockel BJ, Fowler SC (1995) Effects of chronic haloperidol on reaction time and errors in a sustained attention task: partial reversal by anticholinergics and by amphetamine. J Pharmacol Exp Ther 275:1090-1098
7. 2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J Pharmacol Exp Ther 270: 209-218
8. 3 receptor test in vitro predicts decreased cocaine self-administration in rats. Neuroreport 8:2373-2377
9. Civelli O, Bunzow JR, Grandy DK (1993) Molecular diversity of the dopamine receptors. Annu Rev Pharmacol Toxicol 32: 281-307
10. 1 receptors. J Pharmacol Exp Ther 249: 769-774
11. Costall B, Naylor RW, Olley J (1973) Stereotypy and anti-cataleptic action of amphetamine after intracerebral injection. Eur J Pharmacol 18:83-94
12. Delong MR (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci 13:281-285
13. 2 receptor antagonist, (-) eticlopride. Pharmacol Res 31:261-267
14. Giuliani D, Ferrari F (1997) Involvement of dopamine receptors in the antipsychotic profile of (-)eticlopride. Physiol Behav 61: 563-567
15. Hemby SE, Smith JE, Dworkin SI (1996) The effects of eticlopride and naltrexone on responding maintained by food, cocaine, heroin and cocaine/heroin combinations in rats. J Pharmacol Exp Ther 277:1247-1258
16. Joyce EM, Koob GF (1981) Amphetamine, scopolamine, and caffeine-induced locomotor activity following 6-hydroxydopamine lesions of the mesolimbic dopamine systems. Psychopharmacology 73:311-313
17. Kerkman DJ, Ackerman M, Artman LD, Mackenzie RG, Johnson MC, Bednarz L, Montana W, Asin KE, Stampfli H, Kebabian JW (1989) A-69024: a non-benzazepine antagonist with selectivity for the dopamine D-1 receptor. Eur J Pharmacol 166:481-491
18. Levant B, Vansell NR (1997) In vivo occupancy of D2 dopamine receptors by nafadotride. Neuropsychopharmacology 17:67-71
19. 3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc Natl Acad Sci USA 89:8155-8159
20. Marek GJ, Li AA, Seiden LS (1989) Evidence for involvement of 5-hydroxytryptamine 1 receptors in antidepressant-like drug effects on differential-reinforcement-of-low-rate 72-second behavior. J Pharmacol Exp Ther 250:60-71
21. 3 receptor antagonist, activates locomotion in rodents. J Pharmacol Exp Ther 275:1239-1246
22. Skjoldager P, Fowler SC (1988) Effect of pimozide, across doses and within sessions on discriminated lever release performance in rats. Psychopharmacology 96:21-28
23. Statton LM, Solomon PR (1984) Microanalysis of D-amphetamine into the nucleus accumbens and caudate putamen. Physiol Psychol 12:159-162
24. Swerdlow NR, Vaccarino FJ, Amalric M, Koob GF (1986) The neural substrates for the motor-activating properties of psychostimulants. A review of recent findings. Pharmacol Biochem Behav 25:233-248
25. Ungerstedt U, Ljungberg T, Steg G (1974) Behavioral, physiological, and neurochemical changes after 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine neurons. Adv Neurol 5:421-426
26. 2 receptors. Eur J Pharmacol 253:167-169
27. Wise RA (1982) Neuroleptics and operant behavior: the anhedonia hypothesis. Behav Brain Sci 5:39-87